Literature DB >> 1606473

A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies.

S R Hammans1, M G Sweeney, D A Wicks, J A Morgan-Hughes, A E Harding.   

Abstract

Using in situ hybridization and histochemistry we have studied muscle biopsy samples from eight patients with mitochondrial encephalomyopathies and known defects of mitochondrial DNA (mtDNA). In four patients with heteroplasmic mtDNA deletions there were focal accumulations of deleted mtDNA and its transcripts within ragged red fibres (RRF). In one of these, a probe designed specifically to detect deleted mtDNA identified abundant deleted mtDNA and its fusion transcript in RRF and lesser accumulations in non-ragged red cytochrome oxidase (COX) deficient fibres. A further patient with a deletion involving the heavy strand promoter region showed accumulation of deleted mtDNA and light strand transcripts in RRF, but concomitant depletion of all heavy strand transcripts. In all patients with deletions, normal mtDNA transcripts were depleted in COX deficient fibres irrespective of ragged red change. Deleted mtDNA was rare or absent in normal fibres. Within RRF, COX activity was more profoundly impaired in patients with deletions involving COX subunits. In two patients heteroplasmic for the base pair (bp) 3243 mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS), RRF contained a great excess of mtDNA and transcripts of all species. Some RRF showed excess COX activity. Non-ragged red COX deficient fibres showed equal increases of ribosomal RNA (rRNA) and messenger RNA, suggesting that focal biochemical defects were not associated with a quantitative defect of transcription termination at the 3' end of the 16S rRNA which might be predicted. A patient heteroplasmic for the bp 8344 mutation (associated with myoclonic epilepsy and ragged red fibres: MERRF) showed subnormal COX activity within RRF, although the tissue distribution of mtDNA and its transcripts was similar to that seen with the bp 3243 mutation. Within mitochondrial encephalomyopathies, the relationships between the distribution and expression of abnormal mtDNA and the focal biochemical consequences are complex and heterogeneous.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606473     DOI: 10.1093/brain/115.2.343

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  8 in total

Review 1.  Deletions of the mitochondrial genome.

Authors:  A E Harding; S R Hammans
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS.

Authors:  Y Koga; M Davidson; E A Schon; M P King
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

Review 3.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

4.  Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot?

Authors:  C T Moraes; F Ciacci; E Bonilla; C Jansen; M Hirano; N Rao; R E Lovelace; L P Rowland; E A Schon; S DiMauro
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 5.  Mitochondrial DNA diseases: histological and cellular studies.

Authors:  E A Shoubridge
Journal:  J Bioenerg Biomembr       Date:  1994-06       Impact factor: 2.945

Review 6.  Disorders of nuclear-mitochondrial intergenomic signalling.

Authors:  M Zeviani; V Petruzzella; R Carrozzo
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

7.  Mitochondrial myopathy: correlation between oxidative defect and mitochondrial DNA deletions at single fiber level.

Authors:  A Prelle; G Fagiolari; N Checcarelli; M Moggio; A Battistel; G P Comi; P Bazzi; A Bordoni; M Zeviani; G Scarlato
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A-->G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome.

Authors:  E Holme; N G Larsson; A Oldfors; M Tulinius; P Sahlin; G Stenman
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.